Effectiveness and persistence of F/TAF-containing regimens (E/C/F/TAF, R/F/TAF or F/TAF+3rd agent) in late and very late presenters: final 24-month results from the German TAFNES cohort study

Postel, N; Jessen, H; Pauli, R; Hillenbrand, H; Heuchel, T; Rieke, A; Knechten, H; Emmerich, C; Schreiber, S; Mack, F; Haubrich, R; Stellbrink, H

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020; 23 (): 108